Review





Similar Products

vmf  (Selleck Chemicals)
96
Selleck Chemicals vmf
Vmf, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vemurafenib+(vmf/Vemurafenib/10__26650_slash_experimed__1703562-70-15-16
Average 96 stars, based on 1 article reviews
vmf - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier
vemurafenib vmf  (Selleck Chemicals)
96
Selleck Chemicals vemurafenib vmf
Figure 1. % viability for HT-29 cells treated with Acetazolamide (AZA), Rapamycin (RAPA) and <t>Vemurafenib</t> <t>(VMF)</t> for 24 hours at concentrations of 0, 2.5, 5, 10, 25, 50, 100 and 200 μM.
Vemurafenib Vmf, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vemurafenib+(vmf/Vemurafenib/10__14744_slash_ijmb__2022__50455-29-4-13
Average 96 stars, based on 1 article reviews
vemurafenib vmf - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier
vemurafenib (vmf  (Bioconnect Systems Inc)
90
Bioconnect Systems Inc vemurafenib (vmf
Figure 1. % viability for HT-29 cells treated with Acetazolamide (AZA), Rapamycin (RAPA) and <t>Vemurafenib</t> <t>(VMF)</t> for 24 hours at concentrations of 0, 2.5, 5, 10, 25, 50, 100 and 200 μM.
Vemurafenib (Vmf, supplied by Bioconnect Systems Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vemurafenib+(vmf/vemurafenib++vmf/10__1002_slash_bmc__4758-41-10-26
Average 90 stars, based on 1 article reviews
vemurafenib (vmf - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


Figure 1. % viability for HT-29 cells treated with Acetazolamide (AZA), Rapamycin (RAPA) and Vemurafenib (VMF) for 24 hours at concentrations of 0, 2.5, 5, 10, 25, 50, 100 and 200 μM.

Journal: International Journal of Medical Biochemistry

Article Title: Differential in vitro Effects of Oncogenic Pathway Inhibitors on Carbonic Anhydrase- IX, Xanthine Oxidase and Catalase in Colorectal Cancer

doi: 10.14744/ijmb.2022.50455

Figure Lengend Snippet: Figure 1. % viability for HT-29 cells treated with Acetazolamide (AZA), Rapamycin (RAPA) and Vemurafenib (VMF) for 24 hours at concentrations of 0, 2.5, 5, 10, 25, 50, 100 and 200 μM.

Article Snippet: AZA, Rapamycine (RAPA), and Vemurafenib (VMF) were purchased from Sigma-Aldrich, Cayman Chemical, and SelleckChem, respectively.

Techniques:

Figure 3. Xanthine oxidase (XO) activities in HT-29 cells treated with Acetazolamide (AZA), Rapamycin (RAPA), Vemurafenib (VMF) and untreated group.

Journal: International Journal of Medical Biochemistry

Article Title: Differential in vitro Effects of Oncogenic Pathway Inhibitors on Carbonic Anhydrase- IX, Xanthine Oxidase and Catalase in Colorectal Cancer

doi: 10.14744/ijmb.2022.50455

Figure Lengend Snippet: Figure 3. Xanthine oxidase (XO) activities in HT-29 cells treated with Acetazolamide (AZA), Rapamycin (RAPA), Vemurafenib (VMF) and untreated group.

Article Snippet: AZA, Rapamycine (RAPA), and Vemurafenib (VMF) were purchased from Sigma-Aldrich, Cayman Chemical, and SelleckChem, respectively.

Techniques:

Figure 4. Catalase (CAT) activities in HT-29 cells treated with Acetazolamide (AZA), Rapamycin (RAPA), Vemurafenib (VMF) and untreated group.

Journal: International Journal of Medical Biochemistry

Article Title: Differential in vitro Effects of Oncogenic Pathway Inhibitors on Carbonic Anhydrase- IX, Xanthine Oxidase and Catalase in Colorectal Cancer

doi: 10.14744/ijmb.2022.50455

Figure Lengend Snippet: Figure 4. Catalase (CAT) activities in HT-29 cells treated with Acetazolamide (AZA), Rapamycin (RAPA), Vemurafenib (VMF) and untreated group.

Article Snippet: AZA, Rapamycine (RAPA), and Vemurafenib (VMF) were purchased from Sigma-Aldrich, Cayman Chemical, and SelleckChem, respectively.

Techniques: